Document Detail


Maternal serum cytokines in preterm premature rupture of membranes.
MedLine Citation:
PMID:  17197597     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To estimate whether maternal serum interleukin (IL)-6 or granulocyte colony-stimulating factor (G-CSF) obtained daily are elevated in women with preterm premature rupture of membranes who develop funisitis. METHODS: Daily blood samples were obtained from women with preterm premature rupture of membranes and analyzed for IL-6 and G-CSF by enzyme-linked immunosorbent assay. Funisitis was determined by placental examination. Observations were stratified based on the presence or absence of funisitis and analyzed. Proportional hazards models were used to evaluate time-to-delivery on the basis of diagnostic IL-6 and G-CSF levels, determined by receiver operating characteristic curve analysis. RESULTS: Of the 107 patients available for analysis, 54 (50%) had evidence of funisitis after delivery. Patients with funisitis were more likely to deliver at an earlier gestational age (28.5 weeks compared with 31.5 weeks, P<.001) and have Medicaid insurance (57% compared with 39%, P=.04). Serum IL-6 and G-CSF were elevated 24 to 48 hours before delivery in women with preterm premature rupture of membranes with funisitis compared with those without funisitis (IL-6, 7.5 compared with 2.8 pg/mL, P<.001; G-CSF, 121.7 compared with 56.9 pg/mL, P=.002). Using values identified by the receiver operating characteristic curve, elevated serum IL-6 in the interval 24-72 hours before delivery was significantly associated with funisitis (P<.03), even after controlling for gestational age and insurance status. CONCLUSION: Maternal serum IL-6 and G-CSF appear to be biomarkers in the identification of women with preterm premature rupture of membranes likely to develop funisitis. LEVEL OF EVIDENCE: II.
Authors:
Amy P Murtha; Tammy Sinclair; Elizabeth R Hauser; Geeta K Swamy; William N P Herbert; R Phillips Heine
Related Documents :
14712947 - Association between first trimester maternal serum pregnancy associated plasma protein-...
2714507 - Duration of the latency period in preterm premature rupture of the membranes. maternal ...
17572237 - Medical legal issues in the prevention of prematurity.
10819817 - Appendicitis in pregnancy: new information that contradicts long-held clinical beliefs.
698697 - Sampling pure fetal blood by fetoscopy in second trimester of pregnancy.
6459707 - Synthesis of two components of human complement, beta 1h and c3bina, during fetal life.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  109     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2007 Jan 
Date Detail:
Created Date:  2007-01-01     Completed Date:  2007-02-15     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  121-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynecology and Center for Human Genetics, Duke University Medical Center, Durham, NC 27710, USA. murth002@mc.duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Markers / blood
Chorioamnionitis / diagnosis*,  pathology
Female
Fetal Membranes, Premature Rupture / blood*
Granulocyte Colony-Stimulating Factor / blood*
Humans
Interleukin-6 / blood*
Placenta / pathology
Pregnancy
Grant Support
ID/Acronym/Agency:
M01-RR-30/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Interleukin-6; 143011-72-7/Granulocyte Colony-Stimulating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data.
Next Document:  Adaptations of the rat vagina in pregnancy to accommodate delivery.